Insight Molecular Diagnostics (IMDX) Return on Assets (2016 - 2026)

Insight Molecular Diagnostics has reported Return on Assets for 11 years, with the latest figure at 0.02% in Q1 2026.

• Quarterly Return on Assets changed 0.0% year-over-year to 0.02% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.02% (changed 0.0% YoY) and the FY2025 annual result came in at 0.02%, changed 0.0% from the prior year.
• Return on Assets eased to 0.02% in Q1 2026 per IMDX's latest filing, from 0.01% in the prior quarter.
• Over five years, Return on Assets peaked at 0.0% in Q4 2023 and troughed at 0.02% in Q1 2026.
• A 5-year average of 0.01% and a median of 0.0% in 2022 frame the typical range for Return on Assets.
• The sharpest annual moves came in 2022 and 2024: Return on Assets changed 0 bps in 2022, then decreased 1 bps in 2024.
• Over 5 years, Return on Assets stood at 0.0% in 2022, then soared by 91 bps to 0.0% in 2023, then sank by 2801 bps to 0.01% in 2024, then fell by 26 bps to 0.01% in 2025, then declined by 13 bps to 0.02% in 2026.
• According to Business Quant data, Return on Assets over the past three periods registered 0.02%, 0.01%, and 0.01% for Q1 2026, Q4 2025, and Q3 2025 respectively.